Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Hybrid Closed-loop Insulin Delivery System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4658116
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Hybrid Closed-loop Insulin Delivery System market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
This report is a detailed and comprehensive analysis for global Hybrid Closed-loop Insulin Delivery System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hybrid Closed-loop Insulin Delivery System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Hybrid Closed-loop Insulin Delivery System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Hybrid Closed-loop Insulin Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Hybrid Closed-loop Insulin Delivery System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hybrid Closed-loop Insulin Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hybrid Closed-loop Insulin Delivery System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Abbott, Tandem Diabetes, Insulet, Diabeloop, Beta Bionics, Roche, CamDiab, EOFlow, Bigfoot Biomedical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hybrid Closed-loop Insulin Delivery System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Direct Feedback Systems
Indirect Feedback Systems
Market segment by Application
Home Care
Hospitals
Major players covered
Medtronic
Abbott
Tandem Diabetes
Insulet
Diabeloop
Beta Bionics
Roche
CamDiab
EOFlow
Bigfoot Biomedical
Kaleido
Tidepool
Medtrum
Dexcom
Microtech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hybrid Closed-loop Insulin Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hybrid Closed-loop Insulin Delivery System, with price, sales quantity, revenue, and global market share of Hybrid Closed-loop Insulin Delivery System from 2020 to 2025.
Chapter 3, the Hybrid Closed-loop Insulin Delivery System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hybrid Closed-loop Insulin Delivery System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hybrid Closed-loop Insulin Delivery System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hybrid Closed-loop Insulin Delivery System.
Chapter 14 and 15, to describe Hybrid Closed-loop Insulin Delivery System sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hybrid Closed-loop Insulin Delivery System Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Direct Feedback Systems
    • 1.3.3 Indirect Feedback Systems
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hybrid Closed-loop Insulin Delivery System Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Home Care
    • 1.4.3 Hospitals
  • 1.5 Global Hybrid Closed-loop Insulin Delivery System Market Size & Forecast
    • 1.5.1 Global Hybrid Closed-loop Insulin Delivery System Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Hybrid Closed-loop Insulin Delivery System Sales Quantity (2020-2031)
    • 1.5.3 Global Hybrid Closed-loop Insulin Delivery System Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.1.4 Medtronic Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.2.4 Abbott Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Abbott Recent Developments/Updates
  • 2.3 Tandem Diabetes
    • 2.3.1 Tandem Diabetes Details
    • 2.3.2 Tandem Diabetes Major Business
    • 2.3.3 Tandem Diabetes Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.3.4 Tandem Diabetes Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Tandem Diabetes Recent Developments/Updates
  • 2.4 Insulet
    • 2.4.1 Insulet Details
    • 2.4.2 Insulet Major Business
    • 2.4.3 Insulet Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.4.4 Insulet Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Insulet Recent Developments/Updates
  • 2.5 Diabeloop
    • 2.5.1 Diabeloop Details
    • 2.5.2 Diabeloop Major Business
    • 2.5.3 Diabeloop Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.5.4 Diabeloop Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Diabeloop Recent Developments/Updates
  • 2.6 Beta Bionics
    • 2.6.1 Beta Bionics Details
    • 2.6.2 Beta Bionics Major Business
    • 2.6.3 Beta Bionics Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.6.4 Beta Bionics Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Beta Bionics Recent Developments/Updates
  • 2.7 Roche
    • 2.7.1 Roche Details
    • 2.7.2 Roche Major Business
    • 2.7.3 Roche Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.7.4 Roche Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Roche Recent Developments/Updates
  • 2.8 CamDiab
    • 2.8.1 CamDiab Details
    • 2.8.2 CamDiab Major Business
    • 2.8.3 CamDiab Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.8.4 CamDiab Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 CamDiab Recent Developments/Updates
  • 2.9 EOFlow
    • 2.9.1 EOFlow Details
    • 2.9.2 EOFlow Major Business
    • 2.9.3 EOFlow Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.9.4 EOFlow Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 EOFlow Recent Developments/Updates
  • 2.10 Bigfoot Biomedical
    • 2.10.1 Bigfoot Biomedical Details
    • 2.10.2 Bigfoot Biomedical Major Business
    • 2.10.3 Bigfoot Biomedical Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.10.4 Bigfoot Biomedical Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Bigfoot Biomedical Recent Developments/Updates
  • 2.11 Kaleido
    • 2.11.1 Kaleido Details
    • 2.11.2 Kaleido Major Business
    • 2.11.3 Kaleido Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.11.4 Kaleido Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Kaleido Recent Developments/Updates
  • 2.12 Tidepool
    • 2.12.1 Tidepool Details
    • 2.12.2 Tidepool Major Business
    • 2.12.3 Tidepool Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.12.4 Tidepool Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Tidepool Recent Developments/Updates
  • 2.13 Medtrum
    • 2.13.1 Medtrum Details
    • 2.13.2 Medtrum Major Business
    • 2.13.3 Medtrum Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.13.4 Medtrum Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Medtrum Recent Developments/Updates
  • 2.14 Dexcom
    • 2.14.1 Dexcom Details
    • 2.14.2 Dexcom Major Business
    • 2.14.3 Dexcom Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.14.4 Dexcom Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Dexcom Recent Developments/Updates
  • 2.15 Microtech
    • 2.15.1 Microtech Details
    • 2.15.2 Microtech Major Business
    • 2.15.3 Microtech Hybrid Closed-loop Insulin Delivery System Product and Services
    • 2.15.4 Microtech Hybrid Closed-loop Insulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Microtech Recent Developments/Updates

3 Competitive Environment: Hybrid Closed-loop Insulin Delivery System by Manufacturer

  • 3.1 Global Hybrid Closed-loop Insulin Delivery System Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Hybrid Closed-loop Insulin Delivery System Revenue by Manufacturer (2020-2025)
  • 3.3 Global Hybrid Closed-loop Insulin Delivery System Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Hybrid Closed-loop Insulin Delivery System by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Hybrid Closed-loop Insulin Delivery System Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Hybrid Closed-loop Insulin Delivery System Manufacturer Market Share in 2024
  • 3.5 Hybrid Closed-loop Insulin Delivery System Market: Overall Company Footprint Analysis
    • 3.5.1 Hybrid Closed-loop Insulin Delivery System Market: Region Footprint
    • 3.5.2 Hybrid Closed-loop Insulin Delivery System Market: Company Product Type Footprint
    • 3.5.3 Hybrid Closed-loop Insulin Delivery System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hybrid Closed-loop Insulin Delivery System Market Size by Region
    • 4.1.1 Global Hybrid Closed-loop Insulin Delivery System Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Hybrid Closed-loop Insulin Delivery System Consumption Value by Region (2020-2031)
    • 4.1.3 Global Hybrid Closed-loop Insulin Delivery System Average Price by Region (2020-2031)
  • 4.2 North America Hybrid Closed-loop Insulin Delivery System Consumption Value (2020-2031)
  • 4.3 Europe Hybrid Closed-loop Insulin Delivery System Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Hybrid Closed-loop Insulin Delivery System Consumption Value (2020-2031)
  • 4.5 South America Hybrid Closed-loop Insulin Delivery System Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Hybrid Closed-loop Insulin Delivery System Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Hybrid Closed-loop Insulin Delivery System Sales Quantity by Type (2020-2031)
  • 5.2 Global Hybrid Closed-loop Insulin Delivery System Consumption Value by Type (2020-2031)
  • 5.3 Global Hybrid Closed-loop Insulin Delivery System Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Hybrid Closed-loop Insulin Delivery System Sales Quantity by Application (2020-2031)
  • 6.2 Global Hybrid Closed-loop Insulin Delivery System Consumption Value by Application (2020-2031)
  • 6.3 Global Hybrid Closed-loop Insulin Delivery System Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Hybrid Closed-loop Insulin Delivery System Sales Quantity by Type (2020-2031)
  • 7.2 North America Hybrid Closed-loop Insulin Delivery System Sales Quantity by Application (2020-2031)
  • 7.3 North America Hybrid Closed-loop Insulin Delivery System Market Size by Country
    • 7.3.1 North America Hybrid Closed-loop Insulin Delivery System Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Hybrid Closed-loop Insulin Delivery System Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Hybrid Closed-loop Insulin Delivery System Sales Quantity by Type (2020-2031)
  • 8.2 Europe Hybrid Closed-loop Insulin Delivery System Sales Quantity by Application (2020-2031)
  • 8.3 Europe Hybrid Closed-loop Insulin Delivery System Market Size by Country
    • 8.3.1 Europe Hybrid Closed-loop Insulin Delivery System Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Hybrid Closed-loop Insulin Delivery System Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hybrid Closed-loop Insulin Delivery System Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Hybrid Closed-loop Insulin Delivery System Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Hybrid Closed-loop Insulin Delivery System Market Size by Region
    • 9.3.1 Asia-Pacific Hybrid Closed-loop Insulin Delivery System Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Hybrid Closed-loop Insulin Delivery System Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Hybrid Closed-loop Insulin Delivery System Sales Quantity by Type (2020-2031)
  • 10.2 South America Hybrid Closed-loop Insulin Delivery System Sales Quantity by Application (2020-2031)
  • 10.3 South America Hybrid Closed-loop Insulin Delivery System Market Size by Country
    • 10.3.1 South America Hybrid Closed-loop Insulin Delivery System Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Hybrid Closed-loop Insulin Delivery System Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hybrid Closed-loop Insulin Delivery System Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Hybrid Closed-loop Insulin Delivery System Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Hybrid Closed-loop Insulin Delivery System Market Size by Country
    • 11.3.1 Middle East & Africa Hybrid Closed-loop Insulin Delivery System Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Hybrid Closed-loop Insulin Delivery System Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Hybrid Closed-loop Insulin Delivery System Market Drivers
  • 12.2 Hybrid Closed-loop Insulin Delivery System Market Restraints
  • 12.3 Hybrid Closed-loop Insulin Delivery System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hybrid Closed-loop Insulin Delivery System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hybrid Closed-loop Insulin Delivery System
  • 13.3 Hybrid Closed-loop Insulin Delivery System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hybrid Closed-loop Insulin Delivery System Typical Distributors
  • 14.3 Hybrid Closed-loop Insulin Delivery System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Hybrid Closed-loop Insulin Delivery System. Industry analysis & Market Report on Hybrid Closed-loop Insulin Delivery System is a syndicated market report, published as Global Hybrid Closed-loop Insulin Delivery System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Hybrid Closed-loop Insulin Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo